|
gptkbp:instanceOf
|
gptkb:investor
|
|
gptkbp:focusesOn
|
gptkb:insurance
gptkb:technology
|
|
gptkbp:formerName
|
gptkb:Fidelity_Biosciences
|
|
gptkbp:foundedBy
|
gptkb:Fidelity_Investments
|
|
gptkbp:foundedYear
|
1969
|
|
gptkbp:headquartersLocation
|
gptkb:Cambridge,_Massachusetts,_United_States
|
|
gptkbp:industry
|
Venture capital
Private equity
|
|
gptkbp:managingPartner
|
gptkb:Carl_Byers
gptkb:David_J._Calloway
gptkb:Stephen_Knight
|
|
gptkbp:notableInvestment
|
gptkb:Zymergen
gptkb:Relay_Therapeutics
gptkb:Ironwood_Pharmaceuticals
gptkb:Bicycle_Therapeutics
gptkb:Denali_Therapeutics
gptkb:Orchard_Therapeutics
gptkb:Blueprint_Medicines
gptkb:ZappRx
gptkb:CloudHealth_Technologies
gptkb:Iora_Health
gptkb:PatientPing
gptkb:Pulmocide
gptkb:Quanterix
gptkb:Ultragenyx
gptkb:Zagster
|
|
gptkbp:operatesIn
|
gptkb:Europe
gptkb:United_States
|
|
gptkbp:parentOrganization
|
gptkb:Fidelity_Investments
|
|
gptkbp:website
|
https://fprimecapital.com/
|
|
gptkbp:bfsParent
|
gptkb:Beam_Therapeutics
gptkb:Prime_Medicine
gptkb:Sana_Biotechnology
|
|
gptkbp:bfsLayer
|
5
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
F-Prime Capital
|